<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMJ Neurol Open</journal-id><journal-id journal-id-type="iso-abbrev">BMJ Neurol Open</journal-id><journal-id journal-id-type="pmc-domain-id">4001</journal-id><journal-id journal-id-type="pmc-domain">bmjno</journal-id><journal-id journal-id-type="publisher-id">bmjno</journal-id><journal-title-group><journal-title>BMJ Neurology Open</journal-title></journal-title-group><issn pub-type="epub">2632-6140</issn><publisher><publisher-name>BMJ Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11877209</article-id><article-id pub-id-type="pmcid-ver">PMC11877209.1</article-id><article-id pub-id-type="pmcaid">11877209</article-id><article-id pub-id-type="pmcaiid">11877209</article-id><article-id pub-id-type="pmid">40041612</article-id><article-id pub-id-type="doi">10.1136/bmjno-2024-000718</article-id><article-id pub-id-type="publisher-id">bmjno-2024-000718</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>1506</subject></subj-group></article-categories><title-group><article-title>Association between stroke and systemic inflammation response index (SIRI): a National Health and Nutrition Examination Survey (NHANES) Study 2015&#8211;2020</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-6900-4291</contrib-id><name name-style="western"><surname>Valibeygi</surname><given-names initials="A">Adib</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="cor1" ref-type="corresp"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fardaei</surname><given-names initials="M">Mohammadreza</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Niknejad</surname><given-names initials="S">Sepideh</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><aff id="aff1"><label>1</label><institution content-type="department">School of Medicine</institution>, <institution specific-use="Ringgold_158767">Fasa University of Medical Science</institution>, <city>Fasa</city>, <country>Iran (the Islamic Republic of)</country></aff><aff id="aff2"><label>2</label><institution content-type="department">Noncommunicable Disease Research Center</institution>, <institution specific-use="Ringgold_158767">Fasa University of Medical Science</institution>, <city>Fasa</city>, <country>Iran (the Islamic Republic of)</country></aff></contrib-group><author-notes><corresp id="cor1">Dr; <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="avalibeygi98@gmail.com">avalibeygi98@gmail.com</email></corresp><fn fn-type="COI-statement" id="fn4"><p>No, there are no competing interests.</p></fn></author-notes><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>03</day><month>3</month><year>2025</year></pub-date><volume>7</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">480209</issue-id><elocation-id>e000718</elocation-id><history><date date-type="received"><day>21</day><month>3</month><year>2024</year></date><date date-type="accepted"><day>31</day><month>1</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>03</day><month>03</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>03</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-03-06 14:25:29.127"><day>06</day><month>03</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="bmjno-7-1.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="pdf" xlink:href="bmjno-7-1.pdf"/><abstract><title>Abstract</title><sec><title>Objectives</title><p>The present study aimed to compare the relationship between history of stroke and four different inflammatory indices, including high-sensitivity C reactive protein (hsCRP), inflammatory burden index (IBI), neutrophil-to-lymphocyte ratio (NLR), and systemic inflammation response index (SIRI).</p></sec><sec><title>Methods</title><p>In this cross-sectional study, data from the National Health and Nutrition Examination Survey from 2015 to 2020 were used, yielding a sample of 25&#8201;531 participants. Individuals younger than 20, pregnant women, patients with cancer and missing cases were excluded. Baseline characteristics and inflammatory markers mentioned above were analysed. Logistic regression models assessed the association between inflammatory indices and the history of stroke.</p></sec><sec><title>Results</title><p>Of the 7828 eligible cases, 271 (3.4%) had a history of stroke. Stroke was more prevalent among older subjects, smokers, patients with diabetes, hypertension and dyslipidaemia, and those less physically active. All inflammatory indices were elevated considerably in stroke survivors, according to crude analysis. After adjusting for covariates, hsCRP (p=0.519, 95%&#8201;CI: 0.961 to 1.083), NLR (p=0.125, 95%&#8201;CI: 0.947 to 1.565) and IBI (p=0.157, 95%&#8201;CI: 0.991 to 1.060) did not reveal any significant difference between the stroke survivors and control subjects. SIRI was the only inflammatory index significantly associated with a history of stroke (p=0.005, 95%&#8201;CI: 1.154 to 2.274).</p></sec><sec><title>Conclusion</title><p>This study revealed that among the hsCRP, IBI, NLR and SIRI, SIRI is the only one independently associated with a history of stroke. Our findings, in conjunction with the pre-existing evidence from observational and experimental studies, highlight the role of monocytes as a component of SIRI in chronic inflammation, which may induce vascular thrombotic events, including stroke.</p></sec></abstract><kwd-group><kwd>STROKE</kwd><kwd>CEREBROVASCULAR DISEASE</kwd><kwd>CEREBROVASCULAR</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text id="BX1" position="float" orientation="portrait"><sec><title>WHAT IS ALREADY KNOWN ON THIS TOPIC</title><list list-type="bullet" list-content="ul"><list-item><p>There is the relationship between stroke and systemic inflammation.</p></list-item></list></sec><sec><title>WHAT THIS STUDY ADDS</title><list list-type="bullet" list-content="ul"><list-item><p>Among the evaluated inflammatory indices, SIRI is the only one significantly associated with stroke.</p></list-item></list></sec><sec><title>HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY</title><list list-type="bullet" list-content="ul"><list-item><p>We encourage researchers to investigate the relationship between chronic systemic inflammation indicated by the ratio of leucocyte subtypes and the risk of stroke.</p></list-item></list></sec></boxed-text><sec sec-type="intro" id="s1"><title>Introduction</title><p> Stroke, a condition characterised by acute neurological dysfunction due to central nervous system vascular injury, represents a significant global cause of mortality and disability.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> Despite advancements in stroke treatment, it continues to impose a substantial burden on individuals, families and healthcare systems.<xref rid="R2" ref-type="bibr"><sup>2</sup></xref> With a second rank in common causes of death worldwide, stroke accounted for 6.5&#8201;million deaths and 143&#8201;million disability-adjusted life-years in 2021.<xref rid="R3" ref-type="bibr"><sup>3</sup></xref></p><p>In the pathophysiology of cerebral ischaemia, inflammatory processes and other risk factors play a significant role. Numerous inflammation biomarkers have emerged, showing associations with cardiovascular, cerebrovascular, psychiatric and related events over the past two decades.<xref rid="R4" ref-type="bibr"><sup>4 5</sup></xref> In particular, commonly used inflammatory biomarkers like the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and red blood cell distribution width have been identified as inflammatory markers exhibiting predictive value across various fields, including stroke.<xref rid="R6" ref-type="bibr"><sup>6 7</sup></xref> However, their formulations are relatively similar and lack comprehensiveness. Although emerging immune markers have been identified for predicting other diseases,<xref rid="R8" ref-type="bibr"><sup>8</sup></xref> their applicability in stroke prediction remains debatable. Collecting peripheral blood samples is easy and affordable for quantifying these inflammatory biomarkers, offering simplicity, minimal invasiveness and affordability. However, determining the most reliable inflammatory biomarker for stroke prediction remains uncertain. Additionally, establishing optimal cut-off values for these biomarkers is an ongoing endeavour, recognising that selecting the most reliable biomarker and its corresponding cut-off values may vary among studies and populations. Notably, the systemic inflammation response index (SIRI), a novel chronic low-grade inflammatory index, has shown predictive capabilities in glioma,<xref rid="R9" ref-type="bibr"><sup>9</sup></xref> nasopharyngeal carcinoma<xref rid="R10" ref-type="bibr"><sup>10</sup></xref> and breast cancer.<xref rid="R11" ref-type="bibr"><sup>11</sup></xref> Inflammatory burden index (IBI) also emerged as a stand-alone predictor for the prognosis of diverse malignancies and could serve as the optimal indicator among various systemic inflammation markers.<xref rid="R12" ref-type="bibr">12</xref><xref rid="R14" ref-type="bibr">14</xref> Despite its potential, limited research has explored the correlation between SIRI, IBI and stroke. Therefore, we aim to investigate the association between the mentioned inflammatory indices and the history of stroke by addressing the research gap surrounding the link between inflammatory indices and stroke. Ultimately, this knowledge may have significant implications for enhancing stroke prevention and management strategies, thereby reducing the impact of this debilitating condition on individuals and healthcare systems.</p></sec><sec sec-type="materials|methods" id="s2"><title>Materials and methods</title><sec id="s2-1"><title>Study design and population</title><p>National Health and Nutrition Examination Survey (NHANES) is a nationally representative cross-sectional survey studying the nutritional and health status of the civilian non-institutionalised population across the USA. This survey includes interviews, physical examinations and laboratory tests. The Centers for Disease Control and Prevention (CDC) has led this study since 1999.<xref rid="R15" ref-type="bibr"><sup>15</sup></xref> The detailed survey procedure, manuals and documents are freely available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/nchs/nhanes" ext-link-type="uri">https://www.cdc.gov/nchs/nhanes</ext-link>. Datasets are published by CDC.<xref rid="R16" ref-type="bibr">16</xref><xref rid="R18" ref-type="bibr">18</xref></p><p>In the present study, we used the data extracted from the 2015&#8211;2016 and 2017&#8211;2020 cycles. After merging the data, we obtained a total of 25&#8201;531 cases. The flow chart of the study inclusion and exclusion is illustrated in <xref rid="F1" ref-type="fig">figure 1</xref>.</p><fig position="float" id="F1" fig-type="figure" orientation="portrait"><label>Figure 1</label><caption><title>Flow diagram of the selection of eligible participants from the NHANES 2015&#8211;2020. NHANES, National Health and Nutrition Examination Survey.</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="bmjno-7-1-g001.jpg"/></fig></sec><sec id="s2-2"><title>Variables</title><p>Baseline values (age, gender and race) were obtained through interviews. To identify the occurrence of stroke, the patients were asked, &#8220;<italic toggle="yes">Has a doctor or other health professional ever told you that you had a stroke?</italic>&#8221;. Also, other medical conditions diagnosed by physicians, including cancer, pregnancy, diabetes mellitus (DM), hypertension and dyslipidaemia, were inquired through interviews. Individuals who had smoked more than 100 cigarettes in their lives or had secondary household exposure were considered smokers. Physical activity was defined as having moderate to vigorous recreational or work-related activities for at least 5&#8201;days a week. After the interview, the patients were invited to obtain fasting blood samples, through which cell counts and high-sensitivity C reactive protein (hsCRP) were measured. Using the following formula, inflammatory indices were calculated:</p><p>NLR=neutrophil count/lymphocyte count.</p><p>SIRI=neutrophil count&#215;monocyte count/lymphocyte count.</p><p>IBI=neutrophil count&#215;hsCRP/lymphocyte count.</p></sec><sec id="s2-3"><title>Statistical analysis</title><p>After data cleaning and specifying the variables of interest, data analysis was performed by using SPSS V.24. Descriptive statistics were reported as frequency and percentage or mean&#177;SD. The &#967;<sup>2</sup> test was used to study categorical variables. For non-parametric continuous variables, the Kruskal-Wallis test was performed. All primary analyses were followed by logistic regression. Regression findings were reported as not adjusted (model 1), adjusted for age, gender and race (model 2) and adjusted for all covariates (model 3). The p value of less than 0.05 was considered significant.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><p>7828 cases remained after exclusion, among which 3891 (49.7%) were male and 271 (3.4%) had a history of stroke. Descriptive statistics are reported in <xref rid="T1" ref-type="table">table 1</xref>.</p><table-wrap position="float" id="T1" orientation="portrait"><label>Table 1</label><caption><title>Essential characteristics and intergroup analysis of the study population</title></caption><table frame="hsides" rules="groups"><thead><tr><td valign="bottom" rowspan="1" colspan="1">GroupsVariables</td><td valign="bottom" rowspan="1" colspan="1">Stroken=271 (3.5%)</td><td valign="bottom" rowspan="1" colspan="1">Non-stroken=7557 (96.5%)</td><td valign="bottom" rowspan="1" colspan="1">Totaln=7828</td><td valign="bottom" rowspan="1" colspan="1">P value</td></tr></thead><tbody><tr><td valign="top" rowspan="1" colspan="1">Age</td><td align="left" valign="top" rowspan="1" colspan="1">64.32&#177;12.68</td><td align="left" valign="top" rowspan="1" colspan="1">48.20&#177;16.67</td><td align="left" valign="top" rowspan="1" colspan="1">48.76&#177;16.81</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.001<xref rid="T1_FN2" ref-type="table-fn">*</xref></td></tr><tr><td valign="top" rowspan="1" colspan="1">Gender</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">0.684</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;Male</td><td valign="top" rowspan="1" colspan="1">138 (50.9%)</td><td valign="top" rowspan="1" colspan="1">3753 (49.7%)</td><td valign="top" rowspan="1" colspan="1">3891 (49.7%)</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;Female</td><td valign="top" rowspan="1" colspan="1">133 (49.1%)</td><td valign="top" rowspan="1" colspan="1">3804 (50.3%)</td><td valign="top" rowspan="1" colspan="1">3937 (50.3%)</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Race</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.001<xref rid="T1_FN2" ref-type="table-fn">*</xref></td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;African-American</td><td valign="top" rowspan="1" colspan="1">96 (35.4%)</td><td valign="top" rowspan="1" colspan="1">1611 (21.3%)</td><td valign="top" rowspan="1" colspan="1">1707 (21.8%)</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;Non-African-American</td><td valign="top" rowspan="1" colspan="1">175 (64.6%)</td><td valign="top" rowspan="1" colspan="1">946 (78.7%)</td><td valign="top" rowspan="1" colspan="1">6121 (78.2%)</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Active or passive smoking</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.001<xref rid="T1_FN2" ref-type="table-fn">*</xref></td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;Yes</td><td valign="top" rowspan="1" colspan="1">171 (63.1%)</td><td valign="top" rowspan="1" colspan="1">3528 (48.6%)</td><td valign="top" rowspan="1" colspan="1">3699 (47.2%)</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;No</td><td valign="top" rowspan="1" colspan="1">87 (32.1%)</td><td valign="top" rowspan="1" colspan="1">3672 (48.6%)</td><td valign="top" rowspan="1" colspan="1">3759 (48%)</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">DM</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.001<xref rid="T1_FN2" ref-type="table-fn">*</xref></td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;Yes</td><td valign="top" rowspan="1" colspan="1">83 (30.6%)</td><td valign="top" rowspan="1" colspan="1">987 (13.1%)</td><td valign="top" rowspan="1" colspan="1">1070 (13.7%)</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;No</td><td valign="top" rowspan="1" colspan="1">189 (66.4%)</td><td valign="top" rowspan="1" colspan="1">6377 (84.4%)</td><td valign="top" rowspan="1" colspan="1">6557 (83.8%)</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Hypertension</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.001<xref rid="T1_FN2" ref-type="table-fn">*</xref></td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;Yes</td><td valign="top" rowspan="1" colspan="1">192 (70.8%)</td><td valign="top" rowspan="1" colspan="1">2512 (33.2%)</td><td valign="top" rowspan="1" colspan="1">2704 (34.5%)</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;No</td><td valign="top" rowspan="1" colspan="1">79 (29.2%)</td><td valign="top" rowspan="1" colspan="1">5034 (66.6%)</td><td valign="top" rowspan="1" colspan="1">5113 (65.3%)</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Dyslipidaemia</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.001<xref rid="T1_FN2" ref-type="table-fn">*</xref></td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;Yes</td><td valign="top" rowspan="1" colspan="1">167 (61.6%)</td><td valign="top" rowspan="1" colspan="1">2485 (32.9%)</td><td valign="top" rowspan="1" colspan="1">2652 (33.6%)</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;No</td><td valign="top" rowspan="1" colspan="1">103 (38%)</td><td valign="top" rowspan="1" colspan="1">5032 (66.6%)</td><td valign="top" rowspan="1" colspan="1">5135 (65.6%)</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">CAD</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.001<xref rid="T1_FN2" ref-type="table-fn">*</xref></td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;Yes</td><td valign="top" rowspan="1" colspan="1">43 (15.9%)</td><td valign="top" rowspan="1" colspan="1">205 (2.7%)</td><td valign="top" rowspan="1" colspan="1">248 (3.2%)</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;No</td><td valign="top" rowspan="1" colspan="1">225 (83%)</td><td valign="top" rowspan="1" colspan="1">7329 (97%)</td><td valign="top" rowspan="1" colspan="1">7554 (96.8%)</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">PA</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.001<xref rid="T1_FN2" ref-type="table-fn">*</xref></td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;Yes</td><td valign="top" rowspan="1" colspan="1">87 (32.1%)</td><td valign="top" rowspan="1" colspan="1">3628 (48%)</td><td valign="top" rowspan="1" colspan="1">3715 (47.5%)</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;No</td><td valign="top" rowspan="1" colspan="1">183 (67.5%)</td><td valign="top" rowspan="1" colspan="1">3915 (51.8%)</td><td valign="top" rowspan="1" colspan="1">4098 (52.4%)</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">BMI</td><td align="left" valign="top" rowspan="1" colspan="1">26.06&#177;4.76</td><td align="left" valign="top" rowspan="1" colspan="1">28.67&#177;4.60</td><td align="left" valign="top" rowspan="1" colspan="1">28.69&#177;4.60</td><td align="left" valign="top" rowspan="1" colspan="1">0.292</td></tr><tr><td valign="top" rowspan="1" colspan="1">NLR</td><td align="left" valign="top" rowspan="1" colspan="1">1.97&#177;0.61</td><td align="left" valign="top" rowspan="1" colspan="1">1.84&#177;0.55</td><td align="left" valign="top" rowspan="1" colspan="1">1.84&#177;0.55</td><td align="left" valign="top" rowspan="1" colspan="1">0.001<xref rid="T1_FN2" ref-type="table-fn">*</xref></td></tr><tr><td valign="top" rowspan="1" colspan="1">SIRI</td><td align="left" valign="top" rowspan="1" colspan="1">1.14&#177;0.46</td><td align="left" valign="top" rowspan="1" colspan="1">1.01&#177;0.40</td><td align="left" valign="top" rowspan="1" colspan="1">1.02&#177;0.40</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.001<xref rid="T1_FN2" ref-type="table-fn">*</xref></td></tr><tr><td valign="top" rowspan="1" colspan="1">hsCRP</td><td align="left" valign="top" rowspan="1" colspan="1">3.03&#177;2.57</td><td align="left" valign="top" rowspan="1" colspan="1">2.61&#177;2.47</td><td align="left" valign="top" rowspan="1" colspan="1">2.62&#177;2.48</td><td align="left" valign="top" rowspan="1" colspan="1">0.001<xref rid="T1_FN2" ref-type="table-fn">*</xref></td></tr><tr><td valign="top" rowspan="1" colspan="1">IBI</td><td align="left" valign="top" rowspan="1" colspan="1">5.73&#177;4.67</td><td align="left" valign="top" rowspan="1" colspan="1">4.67&#177;4.32</td><td align="left" valign="top" rowspan="1" colspan="1">4.71&#177;4.34</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.001<xref rid="T1_FN2" ref-type="table-fn">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="T1_FN2" fn-type="other"><label>*</label><p>Indicates significance.</p></fn><fn id="T1_FN1" fn-type="abbr"><p>BMI, body mass index ; CADcoronary artery diseaseDM, diabetes mellitus; hsCRP, high-sensitivity C reactive protein; IBI, inflammatory burden indexNLR, neutrophil to lymphocyte ratio; PA, physical activity; SIRI, systemic inflammation response index</p></fn></table-wrap-foot></table-wrap><p>According to the above table, all inflammatory indices significantly differed among individuals with and without stroke. After primary analysis, regression models were established, as explained earlier, which are shown in <xref rid="T2" ref-type="table">table 2</xref>.</p><table-wrap position="float" id="T2" orientation="portrait"><label>Table 2</label><caption><title>Regression models for the association between history of stroke and continuous inflammatory indices</title></caption><table frame="hsides" rules="groups"><thead><tr><td rowspan="2" valign="bottom" colspan="1"/><td colspan="2" valign="bottom" rowspan="1">Model 1</td><td colspan="2" valign="bottom" rowspan="1">Model 2</td><td colspan="2" valign="bottom" rowspan="1">Model 3</td></tr><tr><td valign="bottom" rowspan="1" colspan="1">P value (95%&#8201;CI)</td><td valign="bottom" rowspan="1" colspan="1">OR</td><td valign="bottom" rowspan="1" colspan="1">P value (95%&#8201;CI)</td><td valign="bottom" rowspan="1" colspan="1">OR</td><td valign="bottom" rowspan="1" colspan="1">P value (95%&#8201;CI)</td><td valign="bottom" rowspan="1" colspan="1">OR</td></tr></thead><tbody><tr><td valign="top" rowspan="1" colspan="1">NLR</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.001<xref rid="T2_FN2" ref-type="table-fn">*</xref> (1.209 to 1.823)</td><td align="left" valign="top" rowspan="1" colspan="1">1.485</td><td align="left" valign="top" rowspan="1" colspan="1">0.008<xref rid="T2_FN2" ref-type="table-fn">*</xref> (1.076 to 1.638)</td><td align="left" valign="top" rowspan="1" colspan="1">1.328</td><td align="left" valign="top" rowspan="1" colspan="1">0.125 (0.947 to 1.565)</td><td align="left" valign="top" rowspan="1" colspan="1">1.217</td></tr><tr><td valign="top" rowspan="1" colspan="1">SIRI</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.001<xref rid="T2_FN2" ref-type="table-fn">*</xref> (1.560 to 2.703)</td><td align="left" valign="top" rowspan="1" colspan="1">2.054</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.001<xref rid="T2_FN2" ref-type="table-fn">*</xref> (1.332 to 2.360)</td><td align="left" valign="top" rowspan="1" colspan="1">1.773</td><td align="left" valign="top" rowspan="1" colspan="1">0.005<xref rid="T2_FN2" ref-type="table-fn">*</xref> (1.154 to 2.274)</td><td align="left" valign="top" rowspan="1" colspan="1">1.620</td></tr><tr><td valign="top" rowspan="1" colspan="1">hsCRP</td><td align="left" valign="top" rowspan="1" colspan="1">0.006<xref rid="T2_FN2" ref-type="table-fn">*</xref> (1.017 to 1.109)</td><td align="left" valign="top" rowspan="1" colspan="1">1.062</td><td align="left" valign="top" rowspan="1" colspan="1">0.025<xref rid="T2_FN2" ref-type="table-fn">*</xref> (1.007 to 1.104)</td><td align="left" valign="top" rowspan="1" colspan="1">1.054</td><td align="left" valign="top" rowspan="1" colspan="1">0.519 (0.961 to 1.083)</td><td align="left" valign="top" rowspan="1" colspan="1">1.020</td></tr><tr><td valign="top" rowspan="1" colspan="1">IBI</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.001<xref rid="T2_FN2" ref-type="table-fn">*</xref> (1.025 to 1.077)</td><td align="left" valign="top" rowspan="1" colspan="1">1.05</td><td align="left" valign="top" rowspan="1" colspan="1">0.001<xref rid="T2_FN2" ref-type="table-fn">*</xref> (1.018 to 1.073)</td><td align="left" valign="top" rowspan="1" colspan="1">1.045</td><td align="left" valign="top" rowspan="1" colspan="1">0.157 (0.991 to 1.060)</td><td align="left" valign="top" rowspan="1" colspan="1">1.025</td></tr></tbody></table><table-wrap-foot><fn id="T2_FN1" fn-type="other"><p>Model 1: not adjusted. Model 2: adjusted for age, gender and race. Model 3: adjusted for age, gender, race, BMI, PA, active or passive smoking, DM, CAD, hypertension and dyslipidaemia.</p></fn><fn id="T2_FN2" fn-type="other"><label>*</label><p>Indicates significance.</p></fn><fn fn-type="abbr"><p>BMIbody mass index CADcoronary artery diseaseDMdiabetes mellitushsCRPhigh-sensitivity C reactive proteinIBIinflammatory burden indexNLRneutrophil to lymphocyte ratioNLRneutrophil to lymphocyte ratioPAphysical activitySIRIsystemic inflammation response index</p></fn></table-wrap-foot></table-wrap><p>Regarding the non-normal and highly variable distribution of inflammatory indices, we categorised these variables based on their tertials and repeated the regression analysis, which produced similar findings that SIRI is significantly associated with past history of stroke (as shown in <xref rid="T3" ref-type="table">table 3</xref>). Logistic regression findings are also plotted in <xref rid="F2" ref-type="fig">figure 2</xref>.</p><table-wrap position="float" id="T3" orientation="portrait"><label>Table 3</label><caption><title>Regression models for the association between stroke and categorised inflammatory indices</title></caption><table frame="hsides" rules="groups"><thead><tr><td rowspan="2" valign="bottom" colspan="1"/><td colspan="2" valign="bottom" rowspan="1">Model 1</td><td colspan="2" valign="bottom" rowspan="1">Model 2</td><td colspan="2" valign="bottom" rowspan="1">Model 3</td></tr><tr><td valign="bottom" rowspan="1" colspan="1">P value (95%&#8201;CI)</td><td valign="bottom" rowspan="1" colspan="1">OR</td><td valign="bottom" rowspan="1" colspan="1">P value (95%&#8201;CI)</td><td valign="bottom" rowspan="1" colspan="1">OR</td><td valign="bottom" rowspan="1" colspan="1">P value (95%&#8201;CI)</td><td valign="bottom" rowspan="1" colspan="1">OR</td></tr></thead><tbody><tr><td valign="top" rowspan="1" colspan="1">NLR</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.001<xref rid="T3_FN2" ref-type="table-fn">*</xref> (1.127 to 1.524)</td><td align="left" valign="top" rowspan="1" colspan="1">1.311</td><td align="left" valign="top" rowspan="1" colspan="1">0.003* (1.080 to 1.477)</td><td align="left" valign="top" rowspan="1" colspan="1">1.263</td><td align="left" valign="top" rowspan="1" colspan="1">0.083 (0.979 to 1.408)</td><td align="left" valign="top" rowspan="1" colspan="1">1.174</td></tr><tr><td valign="top" rowspan="1" colspan="1">SIRI</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.001<xref rid="T3_FN2" ref-type="table-fn">*</xref> (1.198 to 1.625)</td><td align="left" valign="top" rowspan="1" colspan="1">1.395</td><td align="left" valign="top" rowspan="1" colspan="1">0.001<xref rid="T3_FN2" ref-type="table-fn">*</xref> (1.131 to 1.558)</td><td align="left" valign="top" rowspan="1" colspan="1">1.327</td><td align="left" valign="top" rowspan="1" colspan="1">0.006<xref rid="T3_FN2" ref-type="table-fn">*</xref> (1.080 to 1.574)</td><td align="left" valign="top" rowspan="1" colspan="1">1.304</td></tr><tr><td valign="top" rowspan="1" colspan="1">hsCRP</td><td align="left" valign="top" rowspan="1" colspan="1">0.001<xref rid="T3_FN2" ref-type="table-fn">*</xref> (1.102 to 1.490)</td><td align="left" valign="top" rowspan="1" colspan="1">1.282</td><td align="left" valign="top" rowspan="1" colspan="1">0.009<xref rid="T3_FN2" ref-type="table-fn">*</xref> (1.054 to 1.446)</td><td align="left" valign="top" rowspan="1" colspan="1">1.235</td><td align="left" valign="top" rowspan="1" colspan="1">0.498 (0.880 to 1.300)</td><td align="left" valign="top" rowspan="1" colspan="1">1.070</td></tr><tr><td valign="top" rowspan="1" colspan="1">IBI</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.001<xref rid="T3_FN2" ref-type="table-fn">*</xref> (1.163 to 1.574)</td><td align="left" valign="top" rowspan="1" colspan="1">1.353</td><td align="left" valign="top" rowspan="1" colspan="1">0.002<xref rid="T3_FN2" ref-type="table-fn">*</xref> (1.091 to 1.496)</td><td align="left" valign="top" rowspan="1" colspan="1">1.277</td><td align="left" valign="top" rowspan="1" colspan="1">0.340 (0.906 to 1.331)</td><td align="left" valign="top" rowspan="1" colspan="1">1.098</td></tr></tbody></table><table-wrap-foot><fn id="T3_FN1" fn-type="other"><p>Model 1: not adjusted. Model 2: adjusted for age, gender and race. Model 3: adjusted for age, gender, race, BMI, PA, active or passive smoking, DM, CAD, hypertension and dyslipidaemia.</p></fn><fn id="T3_FN2" fn-type="other"><label>*</label><p>Indicates significance.</p></fn><fn fn-type="abbr"><p>BMIbody mass indexCADcoronary artery diseaseDMdiabetes mellitushsCRPhigh-sensitivity C reactive proteinIBIinflammatory burden indexNLRneutrophil to lymphocyte ratioPAphysical activitySIRIsystemic inflammation response index</p></fn></table-wrap-foot></table-wrap><fig position="float" id="F2" fig-type="figure" orientation="portrait"><label>Figure 2</label><caption><title>OR and 95% CI of the categorised inflammatory indices in the adjusted regression (model 3). hsCRP, High-sensitivity C reactive protein; IBI, inflammatory burden index; NLR, neutrophil-to-lymphocyte ratio; SIRI, systemic inflammation response index.</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="bmjno-7-1-g002.jpg"/></fig><p><xref rid="F3" ref-type="fig">Figure 3</xref> compares the mean SIRI among individuals with and without stroke, with stroke survivors having higher SIRI.</p><fig position="float" id="F3" fig-type="figure" orientation="portrait"><label>Figure 3</label><caption><title>Boxplot demonstrating the distribution and average of SIRI among individuals with and without stroke. SIRI, systemic inflammation response index.</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="bmjno-7-1-g003.jpg"/></fig></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>The present cross-sectional cohort study was designed to compare various inflammatory indices, some of which were introduced not long ago (ie, SIRI and IBI), among the patients with and without a history of ischaemic stroke. As expected, stroke survivors were significantly older and physically less active. The prevalence of DM, hypertension, dyslipidaemia, smoking and CAD was also higher among these individuals. African-American subjects also were significantly more predisposed to suffer from stroke. Our findings revealed no significant difference between the two groups regarding gender and body mass index.</p><p>Results revealed that all four inflammatory indices were significantly higher among stroke survivors. This finding provides evidence in favour of stroke&#8217;s inflammatory nature. Regression models were then established to adjust the effect of covariates mentioned earlier. As shown earlier, SIRI was the only inflammatory index significantly associated with the history of stroke. Since the inflammatory indices had relatively high variability throughout the population, we categorised these variables based on their tertiles and repeated the analysis, which replicated similar findings.</p><p>While NLR, IBI and hsCRP were not independently related to past stroke, it does not necessarily question the inflammatory nature of cardiovascular events. Despite the conflicts, many previous findings favour the association between hsCRP and stroke in a prospective manner. There is evidence that hsCRP may possess predictive value in risk assessment of major cardiovascular events, including stroke.<xref rid="R19" ref-type="bibr">19</xref><xref rid="R22" ref-type="bibr">22</xref> However, it is not clear whether elevated CRP is maintained over the years after stroke incidence. It is conceivable that after the occurrence of a cardiovascular event, the systemic inflammation of the survivors may be diminished over time by devising secondary preventive measures, such as taking statins, as solid evidence supports this claim for CRP and hsCRP.<xref rid="R23" ref-type="bibr"><sup>23 24</sup></xref></p><p>The significant association between SIRI and stroke history, however, should not be overlooked. Our study is not the first to emphasise the elevated SIRI among stroke survivors. In a recent study on the NHANES database, researchers found that higher SIRI is significantly correlated with higher stroke incidence in asthmatic patients.<xref rid="R25" ref-type="bibr"><sup>25</sup></xref> However, the chronological order of the stroke incidence and rise in SIRI should be evaluated sequentially. While SIRI can be elevated after stroke and tissue ischaemia, the possibility that elevated SIRI may precede a stroke should also be considered.</p><p>Recently, a retrospective cohort study on 4749 elderly hypertensive individuals evaluated various inflammatory indices, including SIRI, NLR and systemic immune inflammation index (SII), in terms of their relationship with the incidence of ischaemic stroke over time, with a median follow-up duration of 3.2 years. It was observed that SIRI outperformed other indices in predicting stroke incidence. This finding not only highlighted the chronic inflammatory status preceding a stroke in hypertensive patients but also showed that SIRI&#8217;s power in the prediction of stroke stood out among other indices.<xref rid="R26" ref-type="bibr"><sup>26</sup></xref> Wei <italic toggle="yes">et al</italic> also found that SIRI is highly correlated with the incidence of myocardial infarction (MI).<xref rid="R27" ref-type="bibr"><sup>27</sup></xref> Another recent study revealed similar findings regarding lower extremity deep vein thrombosis.<xref rid="R28" ref-type="bibr"><sup>28</sup></xref> Additionally, in a large prospective cohort study encompassing over 45&#8201;000 individuals with a median 8.6 years follow-up, Li <italic toggle="yes">et al</italic> found that SIRI is significantly associated with the incidence of cardiovascular diseases, defined as a composite of MI and stroke.<xref rid="R29" ref-type="bibr"><sup>29</sup></xref> SIRI was also found to be associated with stroke incidence in another longitudinal cohort study on roughly 9000 individuals followed for 7.2 years. However, this investigation did not compare SIRI with other conventional or novel inflammatory indices.<xref rid="R30" ref-type="bibr"><sup>30</sup></xref> Finally, in the most extensive study on this subject, Jin <italic toggle="yes">et al</italic> followed nearly 85&#8201;000 individuals for 10 years and compared the effects of SIRI and SII in the prediction of stroke, MI and all-cause mortality. Interestingly, this study found both SIRI and SII to be associated with stroke and all-cause mortality, while only SIRI was associated with MI incidence.<xref rid="R31" ref-type="bibr"><sup>31</sup></xref> These findings suggest that the association between SIRI and atherosclerotic cardiovascular diseases is not limited to stroke. Longitudinal studies also provide evidence that patients experiencing atherosclerotic diseases such as stroke have higher SIRI before an event.</p><p>SIRI is determined based on the interplay between various cellular components of the innate and adaptive immune system (ie, neutrophil, monocyte and lymphocyte). The role of neutrophils in the pathophysiology of stroke is vital. For instance, it has been found that in the animal model of stroke, accumulation of neutrophils in the capillaries after the obstruction of a supplying artery plays a role in preventing the reperfusion and worsening of the tissue ischaemia per se.<xref rid="R32" ref-type="bibr"><sup>32</sup></xref> Despite the critical role of neutrophils in stroke pathophysiology, we emphasise the pivotal role of monocytes. The reason is that neutrophil count and lymphocyte count are shared between the IBI, NLR and SIRI formulas, while monocyte count is exclusive to the SIRI. The role of monocytes in pathophysiology and incidence of stroke has been the focus point of a large body of research.<xref rid="R33" ref-type="bibr"><sup>33</sup></xref> Monocytes are involved in early atherosclerotic plaque formation and plaque rupture by secreting matrix metalloproteinase, leading to thrombosis.<xref rid="R34" ref-type="bibr">34</xref><xref rid="R36" ref-type="bibr">36</xref></p><p>A longitudinal cohort study on more than 14&#8201;000 individuals followed for 11.4 years evaluated the relationship between cardiovascular outcomes and white blood cell (WBC) subtypes. The findings proposed that monocytes, as well as neutrophils, are significantly associated with stroke incidence. When the first 2 years of the follow-up were omitted, results showed that only monocytes were significantly associated with stroke incidence.<xref rid="R37" ref-type="bibr"><sup>37</sup></xref> The most striking investigation on the association between cardiovascular risk and WBC subtypes would probably be the study of Kim <italic toggle="yes">et al</italic>. In this study, monocyte count was the only type of WBC significantly associated with the Framingham risk score as the 10-year predictor of cardiovascular events.<xref rid="R38" ref-type="bibr"><sup>38</sup></xref> The existing evidence is introducing monocytes as the most crucial element of WBCs regarding their association with cardiovascular diseases and stroke.</p><p>Another consideration of the association between SIRI and ischaemic stroke is the subtype and severity of stroke. Likewise, Zhang <italic toggle="yes">et al</italic> found that SIRI was the best predictor of poststroke mortality among other inflammatory indices derived from blood counts.<xref rid="R39" ref-type="bibr"><sup>39</sup></xref> Also, patients with a higher SIRI index are less likely to benefit from revascularisation following stroke and have a poorer prognosis.<xref rid="R40" ref-type="bibr"><sup>40</sup></xref> These findings highlight another aspect of the association between SIRI and stroke.</p><sec id="s4-1"><title>Limitations and strengths</title><p>The major limitation of the present study is its cross-sectional design, which limits our ability to conclude the possible causal relationship between stroke incidence and inflammatory status. Also, a single blood count measurement may not be reliable since some factors such as infections may influence the laboratory results, and some markers may decline over time after stroke. Moreover, the diagnosis of stroke and other medical conditions was based on the interview only. Another limitation of this study is plausible overfitting in model 3 of the regression analysis. Model 3 was adjusted for several covariates which might be a reason for insignificant findings about the relationship between hsCRP or blood cells and stroke.</p><p>On the other hand, the most important strengths to highlight in our study are including a large population of individuals from various ethnic backgrounds across the USA and comparing four different inflammatory indices, which have recently been the point of interest concerning their possible relationship with some systemic diseases, including atherosclerosis.</p></sec></sec><sec sec-type="conclusions" id="s5"><title>Conclusion</title><p>In summary, our findings provide strong evidence supporting the association between SIRI and the history of stroke. It was observed that SIRI was the only index among the four inflammatory indices significantly related to the history of stroke.</p></sec></body><back><ack><title>Acknowledgements</title><p>We would like to thank the CDC and all the NHANES contributors for providing this valuable database and appreciate the participation of all individuals in this survey.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.</p></fn><fn fn-type="other"><p><bold>Data availability free text:</bold> Data are available in a public open access repository at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/nchs/nhanes" ext-link-type="uri">https://www.cdc.gov/nchs/nhanes</ext-link>.</p></fn><fn fn-type="other"><p><bold>Patient consent for publication:</bold> Not applicable.</p></fn><fn fn-type="other"><p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p></fn><fn fn-type="other"><p><bold>Ethics approval:</bold> NHANES adheres to ethical guidelines and is approved by the institutional review board (protocols 2011-17 and 2018-01).</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Werring</surname><given-names>DJ</given-names></name></person-group><article-title>Stroke: causes and clinical features</article-title><source>Medicine (Abingdon)</source><year>2020</year><volume>48</volume><fpage>561</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.mpmed.2020.06.002</pub-id><pub-id pub-id-type="pmid">32837228</pub-id><pub-id pub-id-type="pmcid">PMC7409792</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tu</surname><given-names>W-J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yin</surname><given-names>P</given-names></name><etal>et al</etal></person-group><article-title>Estimated Burden of Stroke in China in 2020</article-title><source><italic toggle="yes">JAMA Netw Open</italic></source><year>2023</year><volume>6</volume><elocation-id>e231455</elocation-id><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2023.1455</pub-id><pub-id pub-id-type="pmid">36862407</pub-id><pub-id pub-id-type="pmcid">PMC9982699</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X-Y</given-names></name><name name-style="western"><surname>Kong</surname><given-names>X-M</given-names></name><name name-style="western"><surname>Yang</surname><given-names>C-H</given-names></name><etal>et al</etal></person-group><article-title>Global, regional, and national burden of ischemic stroke, 1990-2021: an analysis of data from the global burden of disease study 2021</article-title><source>EClinicalMedicine</source><year>2024</year><volume>75</volume><elocation-id>102758</elocation-id><pub-id pub-id-type="doi">10.1016/j.eclinm.2024.102758</pub-id><pub-id pub-id-type="pmid">39157811</pub-id><pub-id pub-id-type="pmcid">PMC11327951</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>D-D</given-names></name><name name-style="western"><surname>Mu</surname><given-names>J-Y</given-names></name><etal>et al</etal></person-group><article-title>Different Types of Circulatory Inflammatory Biomarkers Associated with Cerebral Arterial Atherosclerosis and Dolichoectasia</article-title><source>Cerebrovasc Dis</source><year>2022</year><volume>51</volume><fpage>655</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1159/000522439</pub-id><pub-id pub-id-type="pmid">35259750</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sevil</surname><given-names>E</given-names></name><name name-style="western"><surname>De&#287;er Kulaksiz</surname><given-names>B</given-names></name><name name-style="western"><surname>Islamoglu</surname><given-names>A</given-names></name></person-group><article-title>Association Between the Inflammatory Parameters and Prognosis of Bell&#8217;s Palsy</article-title><source><italic toggle="yes">Northwestern Med J</italic></source><year>2021</year><volume>1</volume><fpage>35</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.5222/NWMJ.2021.03522</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lambertsen</surname><given-names>KL</given-names></name><name name-style="western"><surname>Finsen</surname><given-names>B</given-names></name><name name-style="western"><surname>Clausen</surname><given-names>BH</given-names></name></person-group><article-title>Post-stroke inflammation-target or tool for therapy?</article-title><source>Acta Neuropathol</source><year>2019</year><volume>137</volume><fpage>693</fpage><lpage>714</lpage><pub-id pub-id-type="doi">10.1007/s00401-018-1930-z</pub-id><pub-id pub-id-type="pmid">30483945</pub-id><pub-id pub-id-type="pmcid">PMC6482288</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shekhar</surname><given-names>S</given-names></name><name name-style="western"><surname>Cunningham</surname><given-names>MW</given-names></name><name name-style="western"><surname>Pabbidi</surname><given-names>MR</given-names></name><etal>et al</etal></person-group><article-title>Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches</article-title><source>Eur J Pharmacol</source><year>2018</year><volume>833</volume><fpage>531</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2018.06.028</pub-id><pub-id pub-id-type="pmid">29935175</pub-id><pub-id pub-id-type="pmcid">PMC6090562</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Forrest</surname><given-names>LM</given-names></name><name name-style="western"><surname>McMillan</surname><given-names>DC</given-names></name><name name-style="western"><surname>McArdle</surname><given-names>CS</given-names></name><etal>et al</etal></person-group><article-title>Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer</article-title><source>Br J Cancer</source><year>2003</year><volume>89</volume><fpage>1028</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1038/sj.bjc.6601242</pub-id><pub-id pub-id-type="pmid">12966420</pub-id><pub-id pub-id-type="pmcid">PMC2376960</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>Q</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Ren</surname><given-names>Q</given-names></name></person-group><article-title>The Prognostic Value of Preoperative Systemic Inflammatory Response Index (SIRI) in Patients With High-Grade Glioma and the Establishment of a Nomogram</article-title><source>Front Oncol</source><year>2021</year><volume>11</volume><elocation-id>671811</elocation-id><pub-id pub-id-type="doi">10.3389/fonc.2021.671811</pub-id><pub-id pub-id-type="pmid">34055639</pub-id><pub-id pub-id-type="pmcid">PMC8162213</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>W-Z</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L-L</given-names></name><etal>et al</etal></person-group><article-title>Association of body composition with survival and inflammatory responses in patients with non-metastatic nasopharyngeal cancer</article-title><source>Oral Oncol</source><year>2020</year><volume>108</volume><fpage>104771</fpage><pub-id pub-id-type="doi">10.1016/j.oraloncology.2020.104771</pub-id><pub-id pub-id-type="pmid">32485608</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Kong</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><etal>et al</etal></person-group><article-title>Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator</article-title><source><italic toggle="yes">Cancer Manag Res</italic></source><year>2020</year><volume>12</volume><fpage>1543</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.2147/CMAR.S235519</pub-id><pub-id pub-id-type="pmid">32184659</pub-id><pub-id pub-id-type="pmcid">PMC7060771</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>H</given-names></name><name name-style="western"><surname>Ruan</surname><given-names>G</given-names></name><name name-style="western"><surname>Ge</surname><given-names>Y</given-names></name><etal>et al</etal></person-group><article-title>Inflammatory burden as a prognostic biomarker for cancer</article-title><source>Clin Nutr</source><year>2022</year><volume>41</volume><fpage>1236</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.clnu.2022.04.019</pub-id><pub-id pub-id-type="pmid">35504166</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>H</given-names></name><name name-style="western"><surname>Ruan</surname><given-names>G</given-names></name><name name-style="western"><surname>Wei</surname><given-names>L</given-names></name><etal>et al</etal></person-group><article-title>The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non-small cell lung cancer</article-title><source>J Cachexia Sarcopenia Muscle</source><year>2023</year><volume>14</volume><fpage>869</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1002/jcsm.13199</pub-id><pub-id pub-id-type="pmid">36852672</pub-id><pub-id pub-id-type="pmcid">PMC10067487</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>R</given-names></name><name name-style="western"><surname>Ni</surname><given-names>H</given-names></name><name name-style="western"><surname>Huang</surname><given-names>J</given-names></name><etal>et al</etal></person-group><article-title>Prognostic Value of Inflammation-Immunity-Nutrition Score and Inflammatory Burden Index for Hepatocellular Carcinoma Patients After Hepatectomy</article-title><source>J Inflamm Res</source><year>2022</year><volume>15</volume><fpage>6463</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.2147/JIR.S386407</pub-id><pub-id pub-id-type="pmid">36467989</pub-id><pub-id pub-id-type="pmcid">PMC9717599</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="webpage"><article-title>NCHS ethics review board (ERB) approval: centers for disease control and prevention (CDC)</article-title><year>2022</year><comment>Available</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/nchs/nhanes/irba98.htm" ext-link-type="uri">https://www.cdc.gov/nchs/nhanes/irba98.htm</ext-link></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>National center for health statistics (NCHS)</collab></person-group><article-title>National health and nutrition examination survey data. hyattsville, md: U.S. department of health and human services, centers for disease control and prevention</article-title><year>2015</year><comment>Available</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx?BeginYear=2015" ext-link-type="uri">https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx?BeginYear=2015</ext-link></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>National center for health statistics (NCHS)</collab></person-group><article-title>National health and nutrition examination survey data. Hyattsville, MD: U.S. department of health and human services, centers for disease control and prevention</article-title><year>2017</year><comment>Available</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx?BeginYear=2017" ext-link-type="uri">https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx?BeginYear=2017</ext-link></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>National Center for Health Statistics (NCHS)</collab></person-group><article-title>National health and nutrition examination survey data. Hyattsville, MD: U.S. department of health and human services, centers for disease control and prevention</article-title><year>2017</year><comment>Available</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx?Cycle=2017-2020" ext-link-type="uri">https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx?Cycle=2017-2020</ext-link></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ridker</surname><given-names>PM</given-names></name><name name-style="western"><surname>Buring</surname><given-names>JE</given-names></name><name name-style="western"><surname>Shih</surname><given-names>J</given-names></name><etal>et al</etal></person-group><article-title>Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women</article-title><source>Circulation</source><year>1998</year><volume>98</volume><fpage>731</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1161/01.cir.98.8.731</pub-id><pub-id pub-id-type="pmid">9727541</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ridker</surname><given-names>PM</given-names></name><name name-style="western"><surname>Cushman</surname><given-names>M</given-names></name><name name-style="western"><surname>Stampfer</surname><given-names>MJ</given-names></name><etal>et al</etal></person-group><article-title>Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men</article-title><source>N Engl J Med</source><year>1997</year><volume>336</volume><fpage>973</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1056/NEJM199704033361401</pub-id><pub-id pub-id-type="pmid">9077376</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cao</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Thach</surname><given-names>C</given-names></name><name name-style="western"><surname>Manolio</surname><given-names>TA</given-names></name><etal>et al</etal></person-group><article-title>C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study</article-title><source>Circulation</source><year>2003</year><volume>108</volume><fpage>166</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000079160.07364.6A</pub-id><pub-id pub-id-type="pmid">12821545</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elkind</surname><given-names>MSV</given-names></name></person-group><article-title>Inflammatory mechanisms of stroke</article-title><source>Stroke</source><year>2010</year><volume>41</volume><fpage>S3</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.110.594945</pub-id><pub-id pub-id-type="pmid">20876499</pub-id><pub-id pub-id-type="pmcid">PMC2963080</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alikiaii</surname><given-names>B</given-names></name><name name-style="western"><surname>Heidari</surname><given-names>Z</given-names></name><name name-style="western"><surname>Bagherniya</surname><given-names>M</given-names></name><etal>et al</etal></person-group><article-title>The Effect of Statins on C-Reactive Protein in Stroke Patients: A Systematic Review of Clinical Trials</article-title><source>Mediators Inflamm</source><year>2021</year><volume>2021</volume><elocation-id>7104934</elocation-id><pub-id pub-id-type="doi">10.1155/2021/7104934</pub-id><pub-id pub-id-type="pmid">34489618</pub-id><pub-id pub-id-type="pmcid">PMC8418548</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kandelouei</surname><given-names>T</given-names></name><name name-style="western"><surname>Abbasifard</surname><given-names>M</given-names></name><name name-style="western"><surname>Imani</surname><given-names>D</given-names></name><etal>et al</etal></person-group><article-title>Effect of Statins on Serum level of hs-CRP and CRP in Patients with Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials</article-title><source>Mediators Inflamm</source><year>2022</year><volume>2022</volume><elocation-id>8732360</elocation-id><pub-id pub-id-type="doi">10.1155/2022/8732360</pub-id><pub-id pub-id-type="pmid">35125965</pub-id><pub-id pub-id-type="pmcid">PMC8816584</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>W</given-names></name><name name-style="western"><surname>Bu</surname><given-names>X</given-names></name><name name-style="western"><surname>Xu</surname><given-names>C</given-names></name><etal>et al</etal></person-group><article-title>Higher systemic immune-inflammation index and systemic inflammation response index levels are associated with stroke prevalence in the asthmatic population: a cross-sectional analysis of the NHANES 1999-2018</article-title><source>Front Immunol</source><year>2023</year><volume>14</volume><elocation-id>1191130</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2023.1191130</pub-id><pub-id pub-id-type="pmid">37600830</pub-id><pub-id pub-id-type="pmcid">PMC10436559</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cai</surname><given-names>X</given-names></name><name name-style="western"><surname>Song</surname><given-names>S</given-names></name><name name-style="western"><surname>Hu</surname><given-names>J</given-names></name><etal>et al</etal></person-group><article-title>Systemic Inflammation Response Index as a Predictor of Stroke Risk in Elderly Patients with Hypertension: A Cohort Study</article-title><source>J Inflamm Res</source><year>2023</year><volume>16</volume><fpage>4821</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.2147/JIR.S433190</pub-id><pub-id pub-id-type="pmid">37901383</pub-id><pub-id pub-id-type="pmcid">PMC10612501</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wei</surname><given-names>J</given-names></name><etal>et al</etal></person-group><article-title>Association of systemic immune inflammation index and system inflammation response index with clinical risk of acute myocardial infarction</article-title><source>Front Cardiovasc Med</source><year>2023</year><volume>10</volume><pub-id pub-id-type="doi">10.3389/fcvm.2023.1248655</pub-id><pub-id pub-id-type="pmcid">PMC10498290</pub-id><pub-id pub-id-type="pmid">37711556</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><etal>et al</etal></person-group><article-title>High systemic inflammation response index level is associated with an increased risk of lower extremity deep venous thrombosis: a large retrospective study</article-title><source>Ann Med</source><year>2023</year><volume>55</volume><elocation-id>2249018</elocation-id><pub-id pub-id-type="doi">10.1080/07853890.2023.2249018</pub-id><pub-id pub-id-type="pmid">37604134</pub-id><pub-id pub-id-type="pmcid">PMC10443988</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>He</surname><given-names>D</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J</given-names></name></person-group><article-title>Dynamic status of SII and SIRI alters the risk of cardiovascular diseases: evidence from kailuan cohort study</article-title><source>J Inflamm Res</source><year>2023</year><fpage>5945</fpage><lpage>57</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/JIR.S378309</pub-id><pub-id pub-id-type="pmcid">PMC9584782</pub-id><pub-id pub-id-type="pmid">36274831</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>M</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Chen</surname><given-names>R</given-names></name><etal>et al</etal></person-group><article-title>Individual and combined associations of estimated pulse wave velocity and systemic inflammation response index with risk of stroke in middle-aged and older Chinese adults: a prospective cohort study</article-title><source>Front Cardiovasc Med</source><year>2023</year><volume>10</volume><elocation-id>1158098</elocation-id><pub-id pub-id-type="doi">10.3389/fcvm.2023.1158098</pub-id><pub-id pub-id-type="pmid">38028467</pub-id><pub-id pub-id-type="pmcid">PMC10655141</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>The Associations of Two Novel Inflammation Indexes, SII and SIRI with the Risks for Cardiovascular Diseases and All-Cause Mortality: A Ten-Year Follow-Up Study in 85,154 Individuals</article-title><source>J Inflamm Res</source><year>2021</year><volume>14</volume><fpage>131</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.2147/JIR.S283835</pub-id><pub-id pub-id-type="pmid">33500649</pub-id><pub-id pub-id-type="pmcid">PMC7822090</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El Amki</surname><given-names>M</given-names></name><name name-style="western"><surname>Gl&#252;ck</surname><given-names>C</given-names></name><name name-style="western"><surname>Binder</surname><given-names>N</given-names></name><etal>et al</etal></person-group><article-title>Neutrophils Obstructing Brain Capillaries Are a Major Cause of No-Reflow in Ischemic Stroke</article-title><source>Cell Rep</source><year>2020</year><volume>33</volume><fpage>108260</fpage><pub-id pub-id-type="doi">10.1016/j.celrep.2020.108260</pub-id><pub-id pub-id-type="pmid">33053341</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chiba</surname><given-names>T</given-names></name><name name-style="western"><surname>Umegaki</surname><given-names>K</given-names></name></person-group><article-title>Pivotal roles of monocytes/macrophages in stroke</article-title><source>Mediators Inflamm</source><year>2013</year><volume>2013</volume><elocation-id>759103</elocation-id><pub-id pub-id-type="doi">10.1155/2013/759103</pub-id><pub-id pub-id-type="pmid">23431245</pub-id><pub-id pub-id-type="pmcid">PMC3568889</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Newby</surname><given-names>AC</given-names></name></person-group><article-title>Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture</article-title><source>Physiol Rev</source><year>2005</year><volume>85</volume><fpage>1</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1152/physrev.00048.2003</pub-id><pub-id pub-id-type="pmid">15618476</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ross</surname><given-names>R</given-names></name></person-group><article-title>Atherosclerosis--an inflammatory disease</article-title><source>N Engl J Med</source><year>1999</year><volume>340</volume><fpage>115</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1056/NEJM199901143400207</pub-id><pub-id pub-id-type="pmid">9887164</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnsen</surname><given-names>SH</given-names></name><name name-style="western"><surname>Fosse</surname><given-names>E</given-names></name><name name-style="western"><surname>Joakimsen</surname><given-names>O</given-names></name><etal>et al</etal></person-group><article-title>Monocyte count is a predictor of novel plaque formation: a 7-year follow-up study of 2610 persons without carotid plaque at baseline the Troms&#248; Study</article-title><source>Stroke</source><year>2005</year><volume>36</volume><fpage>715</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1161/01.STR.0000158909.07634.83</pub-id><pub-id pub-id-type="pmid">15746459</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lassale</surname><given-names>C</given-names></name><name name-style="western"><surname>Curtis</surname><given-names>A</given-names></name><name name-style="western"><surname>Abete</surname><given-names>I</given-names></name><etal>et al</etal></person-group><article-title>Elements of the complete blood count associated with cardiovascular disease incidence: Findings from the EPIC-NL cohort study</article-title><source>Sci Rep</source><year>2018</year><volume>8</volume><elocation-id>3290</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-21661-x</pub-id><pub-id pub-id-type="pmid">29459661</pub-id><pub-id pub-id-type="pmcid">PMC5818488</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>J-H</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y-J</given-names></name><name name-style="western"><surname>Park</surname><given-names>B</given-names></name></person-group><article-title>Higher monocyte count with normal white blood cell count is positively associated with 10-year cardiovascular disease risk determined by Framingham risk score among community-dwelling Korean individuals</article-title><source>Medicine (Baltimore)</source><year>2019</year><volume>98</volume><elocation-id>e15340</elocation-id><pub-id pub-id-type="doi">10.1097/MD.0000000000015340</pub-id><pub-id pub-id-type="pmid">31027108</pub-id><pub-id pub-id-type="pmcid">PMC6831393</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xing</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>K</given-names></name><etal>et al</etal></person-group><article-title>The Predictive Role of Systemic Inflammation Response Index (SIRI) in the Prognosis of Stroke Patients</article-title><source>Clin Interv Aging</source><year>2021</year><volume>16</volume><fpage>1997</fpage><lpage>2007</lpage><pub-id pub-id-type="doi">10.2147/CIA.S339221</pub-id><pub-id pub-id-type="pmid">34880606</pub-id><pub-id pub-id-type="pmcid">PMC8645951</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lattanzi</surname><given-names>S</given-names></name><name name-style="western"><surname>Norata</surname><given-names>D</given-names></name><name name-style="western"><surname>Divani</surname><given-names>AA</given-names></name><etal>et al</etal></person-group><article-title>Systemic Inflammatory Response Index and Futile Recanalization in Patients with Ischemic Stroke Undergoing Endovascular Treatment</article-title><source>Brain Sci</source><year>2021</year><volume>11</volume><elocation-id>1164</elocation-id><pub-id pub-id-type="doi">10.3390/brainsci11091164</pub-id><pub-id pub-id-type="pmid">34573185</pub-id><pub-id pub-id-type="pmcid">PMC8468021</pub-id></element-citation></ref></ref-list><sec sec-type="data-availability"><title>Data availability statement</title><p>Data are available in a public, open access repository.</p></sec></back></article></pmc-articleset>